{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:44Z","timestamp":1793407304792,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05418-x","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:15:03Z","timestamp":1767867303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinicopathological features and outcomes in non-functioning pituitary neuroendocrine tumors: a transcription factor-driven subtype analysis"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5430-687X","authenticated-orcid":false,"given":"Weiyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-8038","authenticated-orcid":false,"given":"Zongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"5","key":"5418_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524. https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"Jama"},{"issue":"3","key":"5418_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ecl.2020.05.001","volume":"49","author":"MBS Lopes","year":"2020","unstructured":"Lopes MBS (2020) World Health Organization 2017 classification of pituitary tumors. Endocrinol Metab Clin North Am 49(3):375\u2013386. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.001","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"5418_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol Mar 33(1):6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol Mar"},{"issue":"3","key":"5418_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3171\/2022.12.Jns222118","volume":"139","author":"H Tang","year":"2023","unstructured":"Tang H, Wang X, Bie Z et al (2023) Pituitary adenomas with multiple cell lineage combinations: clinicopathological features and short-term prognosis. J Neurosurg 139(3):810\u2013821. https:\/\/doi.org\/10.3171\/2022.12.Jns222118","journal-title":"J Neurosurg"},{"issue":"6","key":"5418_CR5","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.Jns203236","volume":"135","author":"BA Strickland","year":"2021","unstructured":"Strickland BA, Shahrestani S, Briggs RG et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg 135(6):1706\u20131713. https:\/\/doi.org\/10.3171\/2020.10.Jns203236","journal-title":"J Neurosurg"},{"issue":"10444","key":"5418_CR6","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/s0140-6736(24)00342-8","volume":"403","author":"M Fleseriu","year":"2024","unstructured":"Fleseriu M, Christ-Crain M, Langlois F, Gadelha M, Melmed S (2024) Hypopituitarism. Lancet 403(10444):2632\u20132648. https:\/\/doi.org\/10.1016\/s0140-6736(24)00342-8","journal-title":"Lancet"},{"key":"5418_CR7","doi-asserted-by":"publisher","first-page":"1368944","DOI":"10.3389\/fendo.2024.1368944","volume":"15","author":"CS Woo","year":"2024","unstructured":"Woo CS, Ho RS, Ho G et al (2024) A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification. Front Endocrinol (Lausanne) 15:1368944. https:\/\/doi.org\/10.3389\/fendo.2024.1368944","journal-title":"Front Endocrinol (lausanne)"},{"issue":"1\u20132","key":"5418_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0303-7207(00)00384-1","volume":"171","author":"M Bakke","year":"2001","unstructured":"Bakke M, Zhao L, Hanley NA, Parker KL (2001) SF-1: a critical mediator of steroidogenesis. Mol Cell Endocrinol 171(1\u20132):5\u20137. https:\/\/doi.org\/10.1016\/s0303-7207(00)00384-1","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"5418_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0303-7207(99)00237-3","volume":"163","author":"NA Hanley","year":"2000","unstructured":"Hanley NA, Ikeda Y, Luo X, Parker KL (2000) Steroidogenic factor 1 (SF-1) is essential for ovarian development and function. Mol Cell Endocrinol 163(1\u20132):27\u201332. https:\/\/doi.org\/10.1016\/s0303-7207(99)00237-3","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"5418_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mce.2010.11.019","volume":"336","author":"KW Kim","year":"2011","unstructured":"Kim KW, Sohn JW, Kohno D, Xu Y, Williams K, Elmquist JK (2011) SF-1 in the ventral medial hypothalamic nucleus: a key regulator of homeostasis. Mol Cell Endocrinol 336(1\u20132):219\u2013223. https:\/\/doi.org\/10.1016\/j.mce.2010.11.019","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"5418_CR11","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab 104(7):2473\u20132489. https:\/\/doi.org\/10.1210\/jc.2018-00688","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5418_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1227\/neu.0000000000003512","volume":"97","author":"SL Raub","year":"2025","unstructured":"Raub SL, Fixman B, Hanks T et al (2025) Surgical outcomes of silent ACTH+ corticotroph pituitary neuroendocrine tumors: a multi-institutional experience and review of the literature. Neurosurgery 97(5):1118\u20131123. https:\/\/doi.org\/10.1227\/neu.0000000000003512","journal-title":"Neurosurgery"},{"key":"5418_CR13","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.wneu.2024.08.027","volume":"191","author":"AS Himstead","year":"2024","unstructured":"Himstead AS, Wells AC, Kurtz JS et al (2024) Silent corticotroph adenomas demonstrate predilection for sphenoid sinus, cavernous sinus, and clival invasion compared with other subtypes. World Neurosurg 191:e41\u2013e47. https:\/\/doi.org\/10.1016\/j.wneu.2024.08.027","journal-title":"World Neurosurg"},{"issue":"4","key":"5418_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3171\/2025.3.Jns242823","volume":"143","author":"F Constanzo","year":"2025","unstructured":"Constanzo F, Rychen J, Lee CK et al (2025) Patterns of invasion of the medial wall of the cavernous sinus by pituitary adenomas. J Neurosurg 143(4):895\u2013906. https:\/\/doi.org\/10.3171\/2025.3.Jns242823","journal-title":"J Neurosurg"},{"issue":"5","key":"5418_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3171\/2023.3.Jns221949","volume":"139","author":"K Asmaro","year":"2023","unstructured":"Asmaro K, Zhang M, Rodrigues AJ et al (2023) Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion. J Neurosurg 139(5):1216\u20131224. https:\/\/doi.org\/10.3171\/2023.3.Jns221949","journal-title":"J Neurosurg"},{"issue":"1","key":"5418_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-023-01267-3","volume":"16","author":"N Yan","year":"2024","unstructured":"Yan N, Xie W, Wang D et al (2024) Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors. Genome Med 16(1):2. https:\/\/doi.org\/10.1186\/s13073-023-01267-3","journal-title":"Genome Med"},{"issue":"6","key":"5418_CR17","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.3171\/2020.3.Focus20114","volume":"48","author":"AF Haddad","year":"2020","unstructured":"Haddad AF, Young JS, Oh T et al (2020) Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution. Neurosurg Focus 48(6):E13. https:\/\/doi.org\/10.3171\/2020.3.Focus20114","journal-title":"Neurosurg Focus"},{"issue":"5","key":"5418_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11102-019-00981-9","volume":"22","author":"JP Almeida","year":"2019","unstructured":"Almeida JP, Stephens CC, Eschbacher JM et al (2019) Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers. Pituitary 22(5):514\u2013519.https:\/\/doi.org\/10.1007\/s11102-019-00981-9","journal-title":"Pituitary"},{"key":"5418_CR19","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/j.wneu.2019.06.217","volume":"130","author":"S Aydin","year":"2019","unstructured":"Aydin S, Comunoglu N, Ahmedov ML et al (2019) Clinicopathologic characteristics and surgical treatment of plurihormonal pituitary adenomas. World Neurosurg 130:e765\u2013e774. https:\/\/doi.org\/10.1016\/j.wneu.2019.06.217","journal-title":"World Neurosurg"},{"issue":"16","key":"5418_CR20","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.5444","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos NA, Miller KK (2023) Diagnosis and management of pituitary adenomas: a review. JAMA 329(16):1386\u20131398. https:\/\/doi.org\/10.1001\/jama.2023.5444","journal-title":"JAMA Apr"},{"key":"5418_CR21","doi-asserted-by":"publisher","unstructured":"He W, Yao S, Yu Y et al (2024) Treatment strategies and long-term outcomes in silent corticotroph adenomas: a single-center retrospective study of 367 cases. Neurosurgery. https:\/\/doi.org\/10.1227\/neu.0000000000003142","DOI":"10.1227\/neu.0000000000003142"},{"issue":"3","key":"5418_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.02.169","volume":"101","author":"CS Graffeo","year":"2018","unstructured":"Graffeo CS, Link MJ, Brown PD, Young WF Jr, Pollock BE (2018 Jul 1) Hypopituitarism after single-fraction pituitary adenoma radiosurgery: dosimetric analysis based on patients treated using contemporary techniques. Int J Radiat Oncol Biol Phys 101(3):618\u2013623. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.169","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05418-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05418-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05418-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:22Z","timestamp":1769773642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05418-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5418"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05418-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article has been revised: The equal contribution statement was missing and has now been added.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-sen University (No. [2024]576). And it was a retrospective study (did not involve active interventions) and Clinical trial number: not applicable. The review of clinical data was conducted in accordance with institutional review board (IRB) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}